Omullo FP. Risankizumab redefines Crohn’s treatment after ustekinumab failure. World J Gastrointest Pharmacol Ther 2026; 17(1): 114412 [PMID: 41809223 DOI: 10.4292/wjgpt.v17.i1.114412]
Please LOGIN to submit a new comment.